Director Declaration
4 May 2018 12:00 BST Director Declaration AstraZeneca PLC (the Company) today announced that Sheri McCoy, a Non-Executive Director of the Company, was appointed as a director of Stryker Corporation following the conclusion of its Annual Meeting of Shareholders with effect from 2 May 2018. This announcement is made pursuant to Listing Rule 9.6.14 R (2). About AstraZeneca AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three